
Could taking aspirin halve the risk of bowel cancer?
Episode 193
A daily low dose of aspirin could significantly reduce the risk of bowel cancer in people with Lynch syndrome, an inherited condition that increases the likelihood of developing certain cancers. In this episode, we explore the findings from the landmark CaPP3 trial, hear from a participant living with Lynch syndrome, and discuss how genomics could help shift healthcare from treatment to prevention. Our host, Sharon Jones is joined by: Dr Katie Snape, Principal Clinician for Population Health at Genomics England Professor Sir John Burn, Professor of Clinical Genetics at Newcastle University Drew Hyde, participant in the Ca...
Publisher
Behind the Genes
Link
genomicsengland.podbean.com/e/could-taking-aspirin-halve-the-risk-of-bowel-cancer/
Published
June 24, 2026
Duration
36 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Genomics England
Behind the Genes
@behindthegenes
#takingaspirinhalve #risk #bowelcancer #lifesciences #socialsciences
